GBI Research Market Research Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.

Why purchase an Insight Pharma Report?
Current information on highly relevant topics including biomarkers, pharmacogenomics, molecular diagnostics, predictive toxicology, inflammatory disease therapeutics, metabolic disease therapeutics, and R&D productivity.

Evaluation of the leading trends and breakthroughs within each field, as well as promising early-stage developments.

Analysis of the probability of success for various applications of each technology, and their wider business implications.

Expert insight based on interviews with key personnel in companies at the forefront of technological advances. These experts share their views on their technology's current status, applications in drug development or diagnostics, future direction, and the general market environment.

Competitive insight into the business strategies and activities of key companies. 

Search our comprehensive collection of reports on Markets and Businesses.
Buy reports at huge discounts from leading Market Research companies with deep and extensive industry knowledge.

Use the search box below to find reports.

search:

Featured GBI Research Market Research Reports

TitleDate PublishedPrice fromMore Details
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics
Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptak...
16 Jun 2016 by GBI Research USD $4,995 More Info
Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies
Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Grow...
04 Jul 2016 by GBI Research USD $4,995 More Info
Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period
Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Over...
01 Aug 2016 by GBI Research USD $4,995 More Info
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-C...
01 Aug 2016 by GBI Research USD $6,995 More Info
Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment
Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, ...
01 Aug 2016 by GBI Research USD $4,995 More Info
Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes
Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies ...
01 Aug 2016 by GBI Research USD $6,995 More Info
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of...
01 Aug 2016 by GBI Research USD $4,995 More Info
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer...
01 Aug 2016 by GBI Research USD $4,995 More Info
Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation
Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product In...
01 Sep 2016 by GBI Research USD $6,995 More Info
Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies
Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence...
01 Sep 2016 by GBI Research USD $4,995 More Info

 

More GBI Research Market Research Reports Market Reports

TitleDate PublishedPrice fromMore Details
Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape13 Sep 2016 by GBI Research USD $4,995 More Info
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way01 Sep 2016 by GBI Research USD $6,995 More Info
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth01 Oct 2016 by GBI Research USD $4,995 More Info
Ophthalmology Drug Development Pipeline Review, 201601 Dec 2016 by GBI Research USD $3,995 More Info
Diabetes & Obesity Drug Development Pipeline Review, 201601 Dec 2016 by GBI Research USD $3,995 More Info
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy01 Nov 2016 by GBI Research USD $4,995 More Info
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation01 Nov 2016 by GBI Research USD $6,995 More Info
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD1901 Nov 2016 by GBI Research USD $4,995 More Info
Frontier Pharma: Type 2 Diabetes Mellitus - GPCRs and Protein Kinases Dominate Pipeline, with Most Promising First-in-Class Targets Demonstrating Potential Disease-Modifying Effects01 Dec 2016 by GBI Research USD $6,995 More Info
Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2022 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline01 Dec 2016 by GBI Research USD $4,995 More Info
Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market01 Dec 2016 by GBI Research USD $4,995 More Info
Frontier Pharma: Hepatitis C - Diverse Range of First-in-Class Host-Targeting and Direct-Acting Antivirals Offer Potential in Difficult-to-Treat Populations01 Dec 2016 by GBI Research USD $6,995 More Info
Chronic Obstructive Pulmonary Disease - Heat Map and Analysis10 Jun 2016 by GBI Research USD $2,000 More Info
Prostate Cancer - Heat Map and Analysis01 Sep 2016 by GBI Research USD $2,000 More Info
Type 2 Diabetes Mellitus - Heat Map and Analysis01 Sep 2016 by GBI Research USD $2,000 More Info
Type 1 Diabetes Mellitus - Heat Map and Analysis01 Oct 2016 by GBI Research USD $2,000 More Info
Cystic Fibrosis - Heat Map and Analysis01 Nov 2016 by GBI Research USD $2,000 More Info
Alzheimer's Disease - Heat Map and Analysis01 Nov 2016 by GBI Research USD $2,000 More Info
Melanoma - Heat Map and Analysis02 Nov 2016 by GBI Research USD $2,000 More Info
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments01 Dec 2016 by GBI Research USD $4,995 More Info
COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies01 Jan 2017 by GBI Research USD $4,995 More Info
Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation02 Jan 2017 by GBI Research USD $6,995 More Info
Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies02 Jan 2017 by GBI Research USD $4,995 More Info
Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential05 Jan 2017 by GBI Research USD $6,995 More Info
Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance09 Jan 2017 by GBI Research USD $4,995 More Info
Non-Hodgkin Lymphoma - Heat Map and Analysis06 Jan 2017 by GBI Research USD $2,000 More Info
Parkinson’s Disease - Heat Map and Analysis09 Jan 2017 by GBI Research USD $2,000 More Info
Dermatology Therapeutics Drug Development Pipeline Review, 201615 Dec 2016 by GBI Research USD $3,995 More Info
Colorectal Cancer - Heat Map and Analysis01 Feb 2017 by GBI Research USD $2,000 More Info
Neurodegenerative Disorders Drug Development Pipeline Review, 201721 Mar 2017 by GBI Research USD $3,995 More Info
Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets01 Mar 2017 by GBI Research USD $4,995 More Info
Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products02 Mar 2017 by GBI Research USD $6,995 More Info
Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs01 Apr 2017 by GBI Research USD $4,995 More Info
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market01 Apr 2017 by GBI Research USD $4,995 More Info
Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market01 Jun 2017 by GBI Research USD $4,995 More Info
Pain Drug Development Pipeline Review, 201701 Jul 2017 by GBI Research USD $3,995 More Info
Skeletal Disease Drug Development Pipeline Review, 201701 Jul 2017 by GBI Research USD $3,995 More Info
Transplantation Drug Development Pipeline Review, 201701 Jul 2017 by GBI Research USD $3,995 More Info
Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse01 Jun 2017 by GBI Research USD $4,995 More Info
Frontier Pharma: Dermatology - Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation01 Jun 2017 by GBI Research USD $6,995 More Info

 

>> More GBI Research Market Research Reports Market Research Reports

GBI Research Market Research Reports

You can use this search page to mine our extensive archive of market research and corporate data reports. Type in your search term, company name, market title or other keywords and click return on your keyboard to find matches from our comprehensive library of reports, books and analyses.

  • WorldPay Payments Processing

You can buy reports immediately using our online secure payment service. Payments are processed 100% securely by WorldPay. We accept the following Credit/Debit cards.

Extensive Library of Reports Available

377,868 professional market reports and company analyses now available.

About SPi Reports

We specialise in selling market research and company reports from leading market research publishers. Use our comprehensive search service to find the reports that you're looking for.

Personal Service 

We are based in the UK and are committed to quality customer service. If you need help, contact our sales team for personal assistance: phone +44 (0) 1305 753769 or email office@sectorpublishing.com.